Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 2
2010 1
2011 1
2015 1
2017 2
2019 1
2020 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cabanas r (123 results)?
Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial.
Ferrando C, Carramiñana A, Piñeiro P, Mirabella L, Spadaro S, Librero J, Ramasco F, Scaramuzzo G, Cervantes O, Garutti I, Parera A, Argilaga M, Herranz G, Unzueta C, Vives M, Regi K, Costa-Reverte M, Sonsoles Leal M, Nieves-Alonso J, García E, Rodríguez-Pérez A, Fariña R, Cabrera S, Guerra E, Gallego-Ligorit L, Herrero-Izquierdo A, Vallés-Torres J, Ramos S, López-Herrera D, De La Matta M, Gokhan S, Kucur E, Mugarra A, Soro M, García L, Sastre JA, Aguirre P, Salazar CJ, Ramos MC, Morocho DR, Trespalacios R, Ezequiel-Fernández F, Lamanna A, Pia Cantatore L, Laforgia D, Bellas S, López C, Navarro-Ripoll R, Martínez S, Vallverdú J, Jacas A, Yepes-Temiño MJ, Belda FJ, Tusman G, Suárez-Sipmann F, Villar J; iPROVE-OLV Research Network Group. Ferrando C, et al. Lancet Respir Med. 2024 Mar;12(3):195-206. doi: 10.1016/S2213-2600(23)00346-6. Epub 2023 Dec 5. Lancet Respir Med. 2024. PMID: 38065200 Clinical Trial.
Complications related to less-invasive haemodynamic monitoring.
Belda FJ, Aguilar G, Teboul JL, Pestaña D, Redondo FJ, Malbrain M, Luis JC, Ramasco F, Umgelter A, Wendon J, Kirov M, Fernández-Mondéjar E; PICS Investigators Group. Belda FJ, et al. Br J Anaesth. 2011 Apr;106(4):482-6. doi: 10.1093/bja/aeq377. Epub 2010 Dec 26. Br J Anaesth. 2011. PMID: 21205627 Free article. Review.
Clinical Practice Guideline (CPG). Recommendations on strategy for reducing risk of heart failure patients requiring noncardiac surgery: reducing risk of heart failure patients in noncardiac surgery.
Alvarez Escudero J, Calvo Vecino JM, Veiras S, García R, González A; Working Group of the CPG. Alvarez Escudero J, et al. Rev Esp Anestesiol Reanim. 2015 Aug-Sep;62(7):359-419. doi: 10.1016/j.redar.2015.05.002. Epub 2015 Jul 8. Rev Esp Anestesiol Reanim. 2015. PMID: 26164471 No abstract available.
Use of linezolid in critically ill patients admitted to intensive care units.
Rodríguez O, Alvarez F, Oltra R, Cereijo E, Latorre MM, Martínez H; Study Group for the use of Active Antibiotics against Multiresistant Gram-Positive Cocci in Critically Ill Patients. Rodríguez O, et al. Rev Esp Quimioter. 2009 Jun;22(2):68-75. Rev Esp Quimioter. 2009. PMID: 19554485 Free article.
Effects of oxygen on post-surgical infections during an individualised perioperative open-lung ventilatory strategy: a randomised controlled trial.
Ferrando C, Aldecoa C, Unzueta C, Belda FJ, Librero J, Tusman G, Suárez-Sipmann F, Peiró S, Pozo N, Brunelli A, Garutti I, Gallego C, Rodríguez A, García JI, Díaz-Cambronero O, Balust J, Redondo FJ, de la Matta M, Gallego-Ligorit L, Hernández J, Martínez P, Pérez A, Leal S, Alday E, Monedero P, González R, Mazzirani G, Aguilar G, López-Baamonde M, Felipe M, Mugarra A, Torrente J, Valencia L, Varón V, Sánchez S, Rodríguez B, Martín A, India I, Azparren G, Molina R, Villar J, Soro M; iPROVE-O2 Network. Ferrando C, et al. Br J Anaesth. 2020 Jan;124(1):110-120. doi: 10.1016/j.bja.2019.10.009. Epub 2019 Nov 22. Br J Anaesth. 2020. PMID: 31767144 Free article. Clinical Trial.
Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury.
Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, René R, Livigni S, Ronco C; DOse REsponse Multicentre International collaborative Initiative (DO-RE-MI Study Group). Vesconi S, et al. Crit Care. 2009;13(2):R57. doi: 10.1186/cc7784. Epub 2009 Apr 15. Crit Care. 2009. PMID: 19368724 Free PMC article.